SECreport
Form 4 Revance Therapeutics, For: Mar 21 Filed by: Joshi Abhay
Last revance therapeutics earnings: 8/2 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.revance.com
| IMPACT SNAPSHOT | EVENT TIME: | RVNC | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
RVNC alerts
RVNC alerts
from News Quantified
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RVNC alerts
High impacting REVANCE THERAPEUTICS news events
Weekly update
A roundup of the hottest topics
RVNC
NEWS
NEWS
- Revance Therapeutics to Release Third Quarter 2018 Financial Results on Thursday, November 1, 2018[Business Wire]
- Revance Therapeutics Inc (NASDAQ: RVNC) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating.[MarketBeat]
- Revance Therapeutics appoints Tobin C. Schilke as CFO [Seeking Alpha][Seeking Alpha]
- Revance Therapeutics Appoints Tobin C. Schilke as Chief Financial Officer[Business Wire]
- Revance Therapeutics Inc (NASDAQ: RVNC) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating.[MarketBeat]
- More
RVNC
SEC Filings
SEC Filings
- 10/17/18 - Form 4
- 10/11/18 - Form 8-K
- 9/6/18 - Form CT
- RVNC's page on the SEC website
- More